Skip to main content
. Author manuscript; available in PMC: 2014 May 27.
Published in final edited form as: Biochim Biophys Acta. 2011 Jun 24;1820(6):722–729. doi: 10.1016/j.bbagen.2011.06.017

Figure 1. Scientific overview: An emerging paradigm of nitrogen oxide signaling.

Figure 1

Nitric oxide synthase (NOS) forms S-nitrosothiols (RS˙-˙NO, or, more commonly, RS−NO+). Note there is also regulated cellular import of extracellular S-nitrosothiols. NOS-derived NO and NO reduced from S-nitrosothiols and NO2 can exert classical cytotoxic and cyclic GMP (cGMP)-dependent effects, the latter through activation of guanylyl cyclase (GC). Intracellular S-nitrosothiols can include protein and low-mass species, and are generally in sequestered locations in the cell, such as membranes and vesicles. These S-nitrosothiols can transfer NO+ equivalents to target proteins through transnitrosylation to cause cGMP-independent effects; this signaling can be regulated by movement of the S-nitrosothiols in the cell to target locations, and by degradation. Dr. Lewis’ recent data suggest that S-nitrosothiols can also be secreted into the extracellular space to signal intercellular, cGMP-independent effects—particularly in the autonomic nervous system—through extrusion from S-nitrosothiol-containing vesicles.